A Phase I of SS109 in Hemophilia A or and B With Inhibitors

Clinical trial NCT05651061 · COMPLETED

Trial details

NCT number: NCT05651061
Sponsor: Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hemophilia A With Inhibitor Hemophilia B With Inhibitor Factor VII Deficiency

Start date: 2022-12-14
Primary completion: 2023-03-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.